Cleaning Solutions for Contact Lens Hygiene
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests the long-term safety and effectiveness of three contact lens cleaning solutions for kids and teens. Participants will use one of the OPTI-FREE brand solutions (OPTI-FREE EXPRESS MPDS, OPTI-FREE PureMoist MPDS, or OPTI-FREE REPLENISH MPDS) with their usual contact lenses to evaluate the solutions' performance over a 90-day period. Kids who have worn daily soft contact lenses for at least 8 hours a day, 5 days a week, over the past three months may be suitable for this study. The trial takes place in Canada and the U.S. As an unphased trial, this study allows participants to contribute to valuable research on contact lens care for young people.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but if you use any eye medications or drops that you need to apply during the study, you might not be eligible to participate.
What prior data suggests that these contact lens cleaning solutions are safe for children?
Research shows that the three OPTI-FREE contact lens solutions—Express, PureMoist, and Replenish—are generally safe and well-tolerated.
The OPTI-FREE Express solution effectively cleans and disinfects contact lenses, reducing the risk of eye infections by killing bacteria. OPTI-FREE PureMoist is highly effective against Acanthamoeba, a microorganism that can cause serious eye problems. It cleans and disinfects 99.9% of bacteria, providing comfort and safety for lens users.
The OPTI-FREE Replenish solution features a disinfectant system that reduces harmful microorganisms, helping to prevent eye infections. Users report that their lenses feel clean and moist, and many find it gentle on their eyes.
These solutions are available in stores, indicating their safety. Many people have used them with positive results and few reported side effects.12345Why are researchers excited about this trial?
Researchers are excited about the new contact lens cleaning solutions because they aim to elevate the standard of lens hygiene with unique formulations. Unlike many existing solutions, OPTI-FREE EXPRESS, PureMoist, and REPLENISH MPDS are designed to enhance moisture retention, providing all-day comfort for lens wearers. The PureMoist variant, in particular, includes HydraGlyde Moisture Matrix, which creates a cushion of moisture that lasts throughout the day. These innovative features could lead to improved comfort and protection against eye infections, setting them apart from traditional cleaning solutions.
What evidence suggests that this trial's treatments could be effective for contact lens hygiene?
This trial will compare different OPTI-FREE cleaning solutions for contact lens hygiene. Research has shown that OPTI-FREE cleaning solutions effectively keep contact lenses clean and comfortable. Participants may receive OPTI-FREE EXPRESS, which studies have found can kill 99.9% of bacteria, helping to protect the eyes. Another group will use OPTI-FREE PureMoist, with 88.3% of users reporting all-day comfort and surveys indicating significant improvements in comfort and moisture. A third group will use OPTI-FREE REPLENISH, with 91% of users stating their lenses felt clean and gentle on their eyes. These solutions are well-known for maintaining moisture, cleanliness, and comfort throughout the day.678910
Who Is on the Research Team?
Clinical Trial Lead, Vision Care
Principal Investigator
Alcon Research, LLC
Are You a Good Fit for This Trial?
This clinical trial is for children and teenagers who use contact lenses. They must be willing to follow the study's procedures, including using specific lens cleaning solutions provided by the trial. The exact age range and other specific health requirements are not listed here.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants use OPTI-FREE contact lens solutions with habitual contact lenses for 90 days
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- OPTI-FREE EXPRESS MPDS
- OPTI-FREE PureMoist MPDS
- OPTI-FREE REPLENISH MPDS
Find a Clinic Near You
Who Is Running the Clinical Trial?
Alcon Research
Lead Sponsor
Raquel C. Bono
Alcon Research
Chief Medical Officer since 2022
MD from Harvard Medical School
David Endicott
Alcon Research
Chief Executive Officer since 2018
MBA from University of Southern California